NEW
YORK, Sept. 21, 2022 /PRNewswire/ -- The
Gross Law Firm issues the following notice to shareholders
of Abbott Laboratories.
Shareholders who purchased shares of ABT during the class period
listed are encouraged to contact the firm regarding possible lead
plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/abbott-laboratories-loss-submission-form/?id=31963&from=4
CLASS PERIOD: This lawsuit is on behalf of all persons or
entities who purchased or otherwise acquired shares of Abbott
common stock during the period from February
19, 2021, to June 8, 2022,
inclusive.
ALLEGATIONS: According to the filed complaint, defendants
touted the strength of Abbott's infant formula brands and their
contribution to the Company's sales and revenue growth, despite
knowing that the facility that manufactured those products was in
flagrant violations of United States Food and Drug Administration
("FDA") health, safety, and manufacturing regulations. The
complaint further alleges that defendants willfully or recklessly
concealed these violations from investors, even though the
violations put Abbott's infant formula business in dire jeopardy
and left the Company exposed to a risk of severe regulatory action,
including the recall of its products and closure of the Sturgis
facility. Indeed, according to the complaint, defendants received
direct warnings, communications, FDA inspection reports, and
consumer complaints identifying in detail the safety and regulatory
violations that were rampant at the Sturgis facility.
DEADLINE: October 31, 2022
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/abbott-laboratories-loss-submission-form/?id=31963&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of ABT during the timeframe listed
above, you will be enrolled in a portfolio monitoring software to
provide you with status updates throughout the lifecycle of the
case. The deadline to seek to be a lead plaintiff is October 31, 2022. There is no cost or obligation
to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law Firm is
committed to ensuring that companies adhere to responsible business
practices and engage in good corporate citizenship. The firm seeks
recovery on behalf of investors who incurred losses when false
and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-abbott-laboratories-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-october-31-2022--nyse-abt-301629114.html
SOURCE The Gross Law Firm